Cargando…

Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia

Ischemia occurs when blood flow is reduced or restricted, leading to a lack of oxygen and nutrient supply and removal of metabolites in a body part. Critical limb ischemia (CLI) is a severe clinical manifestation of peripheral arterial disease. Atherosclerosis serves as the main cause of CLI, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Ana Letícia Rodrigues, Willerth, Stephanie M., de la Torre, Lucimara Gaziola, Han, Sang Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866736/
https://www.ncbi.nlm.nih.gov/pubmed/35243296
http://dx.doi.org/10.1016/j.mtbio.2022.100221
_version_ 1784655897357713408
author Costa, Ana Letícia Rodrigues
Willerth, Stephanie M.
de la Torre, Lucimara Gaziola
Han, Sang Won
author_facet Costa, Ana Letícia Rodrigues
Willerth, Stephanie M.
de la Torre, Lucimara Gaziola
Han, Sang Won
author_sort Costa, Ana Letícia Rodrigues
collection PubMed
description Ischemia occurs when blood flow is reduced or restricted, leading to a lack of oxygen and nutrient supply and removal of metabolites in a body part. Critical limb ischemia (CLI) is a severe clinical manifestation of peripheral arterial disease. Atherosclerosis serves as the main cause of CLI, which arises from the deposition of lipids in the artery wall, forming atheroma and causing inflammation. Although several therapies exist for the treatment of CLI, pharmacotherapy still has low efficacy, and vascular surgery often cannot be performed due to the pathophysiological heterogeneity of each patient. Gene and cell therapies have emerged as alternative treatments for the treatment of CLI by promoting angiogenesis. However, the delivery of autologous, heterologous or genetically modified cells into the ischemic tissue remains challenging, as these cells can die at the injection site and/or leak into other tissues. The encapsulation of these cells within hydrogels for local delivery is probably one of the promising options today. Hydrogels, three-dimensional (3D) cross-linked polymer networks, enable manipulation of physical and chemical properties to mimic the extracellular matrix. Thus, specific biostructures can be developed by adjusting prepolymer properties and encapsulation process variables, such as viscosity and flow rate of fluids, depending on the final biomedical application. Electrostatic droplet extrusion, micromolding, microfluidics, and 3D printing have been the most commonly used technologies for cell encapsulation due to their versatility in producing different hydrogel-based systems (e.g., microgels, fibers, vascularized architectures and perfusable single vessels) with great potential to treat ischemic diseases. This review discusses the cell encapsulation technologies associated with hydrogels which are currently used for advanced therapies applied to limb ischemia, describing their principles, advantages, disadvantages, potentials, and innovative therapeutic ideas.
format Online
Article
Text
id pubmed-8866736
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88667362022-03-02 Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia Costa, Ana Letícia Rodrigues Willerth, Stephanie M. de la Torre, Lucimara Gaziola Han, Sang Won Mater Today Bio Review Article Ischemia occurs when blood flow is reduced or restricted, leading to a lack of oxygen and nutrient supply and removal of metabolites in a body part. Critical limb ischemia (CLI) is a severe clinical manifestation of peripheral arterial disease. Atherosclerosis serves as the main cause of CLI, which arises from the deposition of lipids in the artery wall, forming atheroma and causing inflammation. Although several therapies exist for the treatment of CLI, pharmacotherapy still has low efficacy, and vascular surgery often cannot be performed due to the pathophysiological heterogeneity of each patient. Gene and cell therapies have emerged as alternative treatments for the treatment of CLI by promoting angiogenesis. However, the delivery of autologous, heterologous or genetically modified cells into the ischemic tissue remains challenging, as these cells can die at the injection site and/or leak into other tissues. The encapsulation of these cells within hydrogels for local delivery is probably one of the promising options today. Hydrogels, three-dimensional (3D) cross-linked polymer networks, enable manipulation of physical and chemical properties to mimic the extracellular matrix. Thus, specific biostructures can be developed by adjusting prepolymer properties and encapsulation process variables, such as viscosity and flow rate of fluids, depending on the final biomedical application. Electrostatic droplet extrusion, micromolding, microfluidics, and 3D printing have been the most commonly used technologies for cell encapsulation due to their versatility in producing different hydrogel-based systems (e.g., microgels, fibers, vascularized architectures and perfusable single vessels) with great potential to treat ischemic diseases. This review discusses the cell encapsulation technologies associated with hydrogels which are currently used for advanced therapies applied to limb ischemia, describing their principles, advantages, disadvantages, potentials, and innovative therapeutic ideas. Elsevier 2022-02-16 /pmc/articles/PMC8866736/ /pubmed/35243296 http://dx.doi.org/10.1016/j.mtbio.2022.100221 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Costa, Ana Letícia Rodrigues
Willerth, Stephanie M.
de la Torre, Lucimara Gaziola
Han, Sang Won
Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia
title Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia
title_full Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia
title_fullStr Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia
title_full_unstemmed Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia
title_short Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia
title_sort trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866736/
https://www.ncbi.nlm.nih.gov/pubmed/35243296
http://dx.doi.org/10.1016/j.mtbio.2022.100221
work_keys_str_mv AT costaanaleticiarodrigues trendsinhydrogelbasedencapsulationtechnologiesforadvancedcelltherapiesappliedtolimbischemia
AT willerthstephaniem trendsinhydrogelbasedencapsulationtechnologiesforadvancedcelltherapiesappliedtolimbischemia
AT delatorrelucimaragaziola trendsinhydrogelbasedencapsulationtechnologiesforadvancedcelltherapiesappliedtolimbischemia
AT hansangwon trendsinhydrogelbasedencapsulationtechnologiesforadvancedcelltherapiesappliedtolimbischemia